Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma

Published:2002-12-03 Issue:12 Volume:95 Page:2516-2523
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ma Brigette B. Y.,Tannock Ian F.,Pond Gregory R.,Edmonds Matthew R.,Siu Lillian L.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. The role of chemotherapy in the management of nasopharyngeal carcinoma

2. World Health Organization. International classification of tumors: histological typing of upper respiratory tract tumors. Geneva: World Health Organization, 1991.

3. Cancer of the Nasopharynx in British Columbia

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma;Cancers;2022-04-11

2. Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma;Drug Design, Development and Therapy;2022-04

3. Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study;Journal of Clinical Oncology;2021-10-10

4. Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway;Cell Death & Disease;2021-08

5. The safety and efficacy of gemcitabine and cisplatin (GP)‐based induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta‐analysis;European Archives of Oto-Rhino-Laryngology;2021-07-14